JOAQUIN GONZALEZ-MELQUIADES: Open Payments
NPI 1679654099 · BLAIRSTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 49 payments from 15 companies in 2025. Trend: 2023 $508 · 2024 $636 · 2025 $890
Food & beverage: $871Education: $19
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $198 |
| Novo Nordisk Inc | 7 | $127 |
| PFIZER INC. | 6 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| Exact Sciences Corporation | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Lundbeck LLC | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $37 |
Products named: JARDIANCE, MOUNJARO, PREVNAR 20, Ozempic, REXULTI, Kerendia, Cologuard Collection Kit, Rybelsus.
Industry payments across NJ — which companies pay providers there.
